Home > LILACS - Literatura Latinoamericana y del Caribe de Ciencias de la Salud > Search result

Results: 3

Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda

Paumgartten, Francisco José Roma.
Rev. saúde pública (Online); 50 (), 2016
ABSTRACT In the US, where registration of lobbyists is mandatory, the pharmaceutical industry and private health-care providers spend huge amounts of money seeking to influence health policies and government decisions. In Brazil, where lobbying lacks transparency, there is virtually no data on drug indus...
Brasil, Conflicto de Intereses/economía, Conflicto de Intereses/legislación & jurisprudencia, Aprobación de Drogas/economía, Aprobación de Drogas/legislación & jurisprudencia, Industria Farmacéutica/legislación & jurisprudencia, Industria Farmacéutica/organización & administración, Maniobras Políticas, Comunicación Persuasiva, Salud Pública
Fulltext

Food and beverage industries' participation in health scientific events: considerations on conflicts of interest

Canella, Daniela S; Martins, Ana Paula B; Silva, Hugo F R; Passanha, Adriana; Lourenço, Bárbara H.
Rev. panam. salud pública; 38 (4), 2015
Several sectors of the industry (pharmaceutical, food, and other) often occupy a prominent position in scientific meetings on health. The aim of this article is to discuss the participation of food and beverage industries (Big Food and Big Soda) in events organized by scientific institutions in health an...
Industria de Alimentos/ética, Conflicto de Intereses/economía, Industria de Alimentos/economía
Fulltext

Ticagrelor en el síndrome coronario agudo. Explicando lo inexplicable
[Ticagrelor in acute coronary syndrome. Explaining the inexplicable]

Criniti, Juan Martín; Izcovich, Ariel; Popoff, Federico; Ruiz, Juan Ignacio; Catalano, Hugo N.
Medicina (B.Aires); 74 (3), 2014
The PLATO study evaluated the efficacy of adding ticagrelor, instead of clopidogrel, to aspirin in patients with acute coronary syndrome, which showed surprisingly positive results making the drug acceptable to regulatory agencies and specialty societies worldwide. Notwithstanding the aforementioned succ...
Síndrome Coronario Agudo/tratamiento farmacológico, Adenosina/análogos & derivados, Adenosina/uso terapéutico, Ensayos Clínicos como Asunto/ética, Conflicto de Intereses/economía, Medicina Basada en la Evidencia/ética, Apoyo Financiero/ética, Sesgo de Publicación, Factores de Riesgo, Ticagrelor, Resultado del Tratamiento, Estados Unidos, United States Food and Drug Administration
Fulltext